REPORT DOCUMENTATION PAGIlUIh

SECRITY CLASSIFICATION OF THIS PAGE AD-A256 049 Ia. REPORT SECURITY CLASSIFICATION REPORT DOCUMENTATION PAGIlUIh lb. RES-... 2a. SECURITY CLASSIFICATION AUTHORIT 3 DISTRIBUTION /AVAILABILITY OF REPORT 2b. DECLASSIFICATION DOWNGRA I I L',. D 4. PERFORMING ORGANIZATION RE 5. MONITORING ORGANIZATION REPORT NUMBER(S) 6a. NAME OF PERFORMING ORGANIZATION 6b. OFFICE SYMBOL 7a. NAME OF MONITORING ORGANIZATION Walter Reed Army Institute of (If applicable) Wa4Xer Reed Army Institute of Research Research, Wash- DC 20307-5100 6c. ADDRESS (C/ty, State, and ZIP Code) 7b. ADDRESS (City, State, and ZIP Code),EC =-0751-0D Washington, DC 20307-5100 Ba. NAME OF FUNDING /SPONSORING 8b. OFFICE SYMBOL 9. PROCUREMENT INSTRUMENT IDENTIFICATION NUMBER ORGANIZATION (if applicable) Sc. ADDRESS (Cty, State, and ZIP Code) 10. SOURCE OF FUNDING NUMBERS PROGRAM PROJECT TASK WORK UNIT U.S. Medical Research and Developmnt ELEMENT NO. NO. NO. ACCESSION NO. Corwiand 11. TITLE (Induo Securty Oasfication) Develpment and Evaluation of an Enzyme-Linked Immunosorbent Assay for Plasmodium vivax- VK347 Sporozoites 12. PERSONAL AUTHOR(S) RobertA.Wirtz, Jetsumon Sattabongkot, Ted Hall, Thomas R. Burkot, and Ronald Rosenberg 13a. TYPE OF REPORT 13b. TIME COVERED 14. DATE OF REPORT (Year. Month, Day) IS. PAGE COUNT FROM _ TO_ 16. SUPPLEMENTARY NOTATION 17. COSATI CODES 18. SUBJECT TERMS (Continue on reverse if necessary and identify by block number) FIELD GROUP SUB-GROUP Plasfrxhiviv circumsporozoites protein detection ELISA 19% ABSTRACT (Continue on reverse if necessary and identify by block number) An enzymed-linked immunosorbent assay (ELISA) for the Plasmodium vivax-vk247 (variant) circumsporozoite (CS) protein was developed and evaluated using sporozoites produced by feeding mosquitoes onthaipatients with parasitologically confirmed P. vivax infections. The ELISA had a detection threshold df f3esr than 50 sporozoites. Using this assay in conjunction with an ELISA for the VK210 polymorph, nearly 16% of the 235 P. vivax cases produced sporozoites positive only for the variant; 69% produced sporozoites positive only in the VK210 assay; and 15% were positive in both assays,indicating mixed infections. Twelve cases (5%) produced sporozoites negative-inone assay and with unexpectedly low activity in the other ELISA,indicating the possibility of other CS protein polymorphs. 20. DISTRIBUTION /AVAILABILITY OF ABSTRACT 21 ABSTRACT SECURITY CLASSIFICATION r-ounclassified)unlimited 0] SAME AS RPT. 0 DTIC USERS 22&. NAME OF RESPONSIBLE INDIVIDUAL 22b TELEPHONE (Include Area Code) 22c. OFFICE SYMBOL DD Form 1473, JUN 86 Previous editions are obsolete. SECURITY CLASSIFICATION OF THIS PAGE

l - -7 Development and Evaluation of an Enzyme-Linked Immunosorbent Assay for Plasmodium vivax-vk247 Sporozoites ROBERT A. WIRTZ, JETSUMON SATTABONGKOT,' TED HALL,2 THOMAS R. BURKOT,3 AND RONALD ROSENBERG' Department of Entomology, Division of Communicable Disease and Immunology, Walter Reed Army Institute of Research, Washington, D.C. 20307-51(X ),,, _I--- J. Med. Entornol. 29(5): 854-857 (19942 ABSTRACT An enzyme-linked immunosorbent assay (ELISA) for the Plasrnodium vicax-vk247 (variant) circumsporozoite (CS) protein was developed and evaluated using sporozoites produced by feeding mosquitoes on Thai patients with parasitologically con- - firmed P. vivax infections. The ELISA had a detection threshold of fewer than 50 sporo- C zoites. Using this assay in conjunction with an ELISA for the VK210 polymorph. nearly 16% of the 235 P. ciuax cases produced sporozoites positive only for the variant; 69/ Ic produced sporozoites positive only in the VK210 assay; and 15% were positive in both N assays, indicating mixed infections. Twelve cases (5%) produced sporozoites negative in one assay and with unexpectedly low activity in the other ELISA, indicating the possibility of other CS protein polymorphs. KEY WORDS Plasmodium cicax, circumsporozoite protein detection, ELISA (/j 92 10 5 ENZYME-LINKED INMIUNOSORBENT assays et al. (1991). Briefly. laboratory-reared Anopheles (ELISAs) for the detection of Plasmodiuni ciuax dirus Peyton & Harrison (Bangkok colony) were (Grassi & Feletti) and P. falciparurn (Welch) cir- fed on volunteer patients who reported to macumsporozoite (CS) proteins in anopheline mos- laria clinics and who were found to have at least quitoes have become valuable tools to study ma- one P. vivax gametocyte per 50 fields (700x) on a laria (Wirtz & Burkot 1991). The recent discovery Giemsa-stained thick blood film. Mosquitoes ofa P. vivax polymorph (VK247) that produces an were examined for oocysts 7-10 d after feeding, immunologically distinct CS protein, not detect- and positive groups were checked for salivary able with existing ELISAs (Rosenberg et al. gland sporozoites 14-16 d after feeding. Blood 1989), has made it necessary to develop an assay slides were rechecked, and only mosquitoes that for the variant sporozoites. The VK247 poly- had fed on volunteers with confirmed, uncomplimorph is widespread in Asia and Latin America, cated P. citax infections were used for further based on studies of P. vicax sporozoites (Rosen- study. berg et al. 1989). blood-stage parasites (Kain et Salivary glands were dissected from infected al. 1992), and detection of human antibody to the mosquitoes and sporozoites were harvested by VK247 CS protein (Cochrane et al. 1990, Wirtz et transferring the glands into 1.5-ml tubes containal. 1990). We report herein the development and ing 0.01 M phosphate-buffered saline (PBS), ph initial evaluation of an ELISA for the P. vivax- 7.4. Glands were ground gently with a pestle VK247 CS protein in anopheline mosquitoes. (Kontes, Vineland. NJ) to release the sporozoites. which were counted using a hemocytometer. Materials and Methods Sporozoites used for monoclonal antibody (MAb) production and ELISA development were frozen Sporozoite Production. Details of sporozoite at -70'C and then shipped on dry ice to the production have been described by Sattabongkot Walter Reed Army Institute of Research. Sporozoites for evaluating the ELISA in Thai- Department of Entomology. U.S. Army Medical Compo- land were diluted to 1.600 sporozoites per 50 Al nent. 315-16 Raiavithi Rd., Bangkok. Thailand. o0.5% boiled casein blocking buffer containing 2 Department of Immunology. Division of Communicable Disease and Immunology. Walter Reed Army Institute of g, 0.05% Nonidet P40 (Sigma Chemical Co., St. search, Washington. DC 20307-5100. Louis, MO). The blocking buffer was prepared 3 Tropical Health Program. Queensland Institute of Medical by boiling 5 g of bovine milk casein (Sigma Research, Bramston Terrace. Herston, Queensland. 4006. Aus- Chemical Co.. catalog no. C-0376) in 100 ml of tralia. Current address: Centers for Disease Control. Division of Vector-Bome Infectious Diseases. P.O. Box 2087, Fort Col. 0.1 M NaOH. adding 900 mil of PBS, adjusting lins, CO 80521. the ph to -7.4 with HC!, and adding 0.01%

September 1992 WIRTZ ET AL.: P. vivax-vk247 SPOROZOITE ELISA 855 thimerosal plus 0.002% phenol red. Samples not ride microtiter plates (Dynatech Laboratories, immediately tested weie frozen at -70 0 C for Inc., Alexandria, VA). Wells were aspirated dry, later use. Serial (1:1) dilutions of sporozoites filled with blocking buffer for I h, aspirated dry, were tested in the VK210 and VK247 ELISAs. and positive control antigen or sporozoites di- The picogram equivalents were determined, luted in blocking buffer were added to the apbased on dilution curves ofnsiv20 recombinant propriate wells. After 2 h, wells were aspirated protein (Gordon et al. 1990) and synthetic dry, washed twice with PBS-0.05% Tween 20, peptide (Ala-Asn-Gly-Ala-Gly-Asn-Gln-Pro-Gly) 3 and the homologous peroxidase-conjugated MAb (Rosenberg et al. 1989) glutaraldehyde conju- diluted in blocking buffer was added. After I h gated to boiled casein (VK247 3 -BC) positive con- wells were aspirated dry, washed three times trol CS antigens, respectively, run in the same with PBS-0.05% Tween 20, and 100 Al of ABTS microtiter plate. peroxidase substrate (Kirkegaard & Perry Labo- Sporozoites used for MAb production were ratories) were added to each well. Absorbance from mosquitoes fed on patients in Kanchanaburi (405 nm) values were recorded after 1 h with anl or Ratchaburi provinces, in western Thailand ELISA plate reader (Molecular Devices Corpowhere the VK247 strain was discovered (Rosen- ration, Menlo Park, CA). Assays were conducted berg et al. 1989). Some sporozoites used to at room temperature, and plates were covered evaluate the ELISA also were produced from during incubations to prevent evaporation. patients in Nakhon Si Thammarat and Trat provinces in southern and eastern Thailand, respec- Optimum VK247 ELISA capture and peroxi- dase-conjugated MAb concentrations were detiveiy (Sattabongkot et al. 191). termined using serial (1:1) dilutions beginning at Monoclonal Antibody Development. The 0.4 Ag/50 Ml (8 Ag/ml) and using VK247 3 -BC as MAbs were developed using the method de- the positive control. The VK210 ELISA was conscribed by Burkot et al. (1984). Hybridomas were ducted using capture and peroxidase-conjugated produced from BALB/c mice given -200,000 MAb concentrations of 0.025 and 0.05 Lg per sporozoites, which tested negative in the VK210 well (Wirtz et al. 1991), respectively, and ELISA, in 100 Al PBS by intravenous tail vein NS1V20 recombinant protein, containing 20 Glyinjection on day 0, and 100,000 sporozoites per Asp-Arg-Ala-(Ala/Asp)-Gly-Gln-Pro-Ala repeats 50 Al on days 20 and 40. These mice also re- (Gordon et al. 1990), as the positive control. The ceived 50 Mg of VK247 synthetic peptide (Ala- sporozoites used to evaluate the assays were pro- Asn-Gly-Aia-GIy-Asn-GIn-Pro-Gly) 3 (Rosenberg duced by feeding mosquitoes on patients WR8 et al. 1989) (University of Maryland Biopolymer and VK744 (Rosenberg et al. 1989), respectively. Laboratory, Baltimore, MID), glutaraldehyde conjugated to keyhole limpet hemocyanin (Cal- Results and Discussion biochem, La Jolla, CA) in 100 Ml of PBS on days 20 and 40. On day 60, 3 d before the fusion, mice Four fusions were required to produce stable received 100,000 sporozoites in 50 Al PBS. Hy- IgG-secreting cell lines. Two initial fusions rebridoma cell culture supernatants were screened suited in unstable hvbridomas or those that profor activity by indirect immunofluoroscence an- duced only lgm MAbs unacceptable because of tibody assay (IFA), using air-dried sporozoites (Wirtz et al. 1991), or by antibody ELISA (Wirtz low sensitivity and high background absorbance values (data not shown). Six IgG-secreting cell et al. 1990), using VK247v-BC as the capture an- lines from two subsequent fusions were selected tigen in conjunction with peroxidase anti-mouse for ascites production, based on cell culture su- IgG (H+L) (Kirkegaard & Perry Laboratories, pernatant IFA and ELISA results. Comparative Inc., Gaithersburg, MD). Isotyping was con- testing of these protein A purified MAbs resulted ducted by Ouchteriony immunodiflusion or by in the selection of two for peroxidase conjugation antibody ELISA using IgG (y) and IgM (M) class- (182.1G12 and 182.2G5). specific anti-mouse antibodies (Sigma Chemical The optimum capture and peroxidase- Co.). conjugate concentrations for both 182.1G12 and Ascitic fluid was produced from six cloned cell 182.2G5 MAbs were 0.1 ug/50 ALI PBS (2 Mg/ml) lines, purified by protein-a column chromatog- and 0.2 ug/50 Ml blocking buffer (4 Mg/ml), reraphy (Ey et al. 1978) and evaluated by IFA. The spectively, when using VK247,-BC synthetic two most promising MAbs were conjugated to peptide or Nonidet P-40 treated sporozoites. horseradish peroxidase, aliquoted, and lyophyl- When testing sporozoite concentrations in the ized (Kirkegaard & Perry Laboratories). Lyo- 50-400 per well range, lower (0.05 Mg) or higher phylized reagents were dissolved in glycerol: (0.2 Ag) concentrations of capture 182.2G5 MAb distilled water (1:1) to yield working stock resulted in 10-20% and 30-50% decreases in solutions of 0.5 mg MAb/mI. absorbance values, respectively. Using lower Sporozoite ELISA Method. A two-site homol- (0.1 Ag) or higher (0.4 Mg) peroxidase-182.2g5 ogous "sandwich" ELISA was developed (Wirtz MAb concentrations resulted in a 15-30% reducet al. 1991). Capture MAb diluted in PBS was tion or 10-15% increase in absorbance values, incubated overnight in wells of polyvinyl chlo- respectivelv. However, background absorbance

856 JOURNAL OF MEDICAL ENTOMOLOGY Vol. 29, no. 5 PLAMDUM VIVAX SPOROZOITES / WELL 0 12.5 25 50 100 200 400 2.0 1 1 1 1 1 2.0 E o WR 8 sporozoites c 1.5 H VK 744 sporozoites O NSIV20 CS protein 1.5 Z 0 VK247 CS protein.n S1.0 1.0 0 0.5 0.5 0 L_ 09 _ 0 0 1.25 2.5 5.0 10 20 40 NSIV20 (0) 0 125 250 500 1000 2000 4000 VK247 (0) Pg CIRCUMSPOROZOITE PROTEIN / WELL Fig. 1. Sensitivity of Plasmodium vivax VK247 (182.2G5) (closed symbols) and VK210 (NVS#3) (open symbols) ELISAs for Nonidet P-40-treated sporozoites, synthetic VK247, and recombinant VK210 circumsporozoite proteins (Monoclonal antibody concentrations: VK247-182.2G5 capture and peroxidase = 0.1 and 0.2 j~g/50 g) per well; VK210-NVS#3 capture and peroxidase = 0.025 and 0.05 jg/50 Ail per well; substrate reaction time = I h). values were consistently higher when more P. vivax-infected patients (15.3%) produced spoenzyme-conjugate was used. Results with the rozoites positive in the VK247 ELISA (>2,000 182.1G12 MAb were nearly identical. pg) and negative in the P. vivax-predominant The VK247-182.2G5 and VK210-NVS#3 (VK210) CS protein assay (<5 pg). This is similar ELISA CS antigen and sporozoite dilution to the initial report that 14.2% (23/162) of pacurves are shown in Fig. 1. The lower detection tients from the same geographic area produced limits of the VK247-182.2G5 and VK210-NVS#3 sporozoites that did not react in the VK210 ELISAs are -50 and 25 sporozoites, respec- ELISA (Rosenberg et al. 1989). Thirty-six patively, using a cut-off value of two times the tients (15%) produced sporozoites positive in mean of six negative control wells containing both assays, indicating concurrent VK247 and blocking buffer (0.18 and 0.16, respectively). The VK210 infections, or sporozoites containing both 103 pg difference in sensitivity between the CS proteins; therefore -30% of all P. vivax cases VK247 3 -BC and NS1V20 antigens (Fig. 1; Table were infected with the VK247 polymorph. The 1) can be attributed to their structures. The NSIV20 recombinant protein contains 20 nonapeptide repeats plus 81 N-terminal amino acids Table 1. ELISA dete inination of P. visao VK247 and VK210 eircumaporouoite protein concentrations aaaoci- (Gordon et al. 1990). The VK247 synthetic pep- sted with 1,600 salivary gland sporozoaites produced from tide consists of only three nonapeptide repeats each of 235 mosquito feeds on P. vivaz-lnfected patients conjugated to boiled casein, which mav reduce from Thailand the number of functional epitopes. Similar ditferences in sensitivity were observed when VK247'EL SA VK2?OELISApg these reagents were used as ELISA captu (pa X 10') 0 >5-20 21-80 81-160 >160 Total (%) tigens to screen for anti-cs antibody in human >32 9 5 7 7 7 35 (14.9) 17-32 18 0 1 3 I 23 (9.8) sera (Wirtz et al. 1990). >2-16 9 0 0, 2 14 (5.61 The VK247 or VK210 CS protein equi% alent of o U 1b 50 92 163 (69.4) 1,600 sporozoites from each patient feed was Total 36 8 26 63 102 235(100) used fo construct Table 1. Thirty-six of the 235 () (15.3) (3.4) (11.1) (26.8) (43.4) (100)

September 1992 WIRTZ ET AL.: P. vivax-vk247 SPOROZOITE ELISA 857 remaining 69% (163/233) of the cases produced Cochrane, A. H., E. H. Nardin, M. de Arruda, M. Masporozoites positive only in the VK2.1O assay. racic, P. Clavijo, W. E. Collins & R. S. Nussenz- Three patients (1%) produced sporozoites that weig. 1990. Widespread reactivity of human sera were negative in the VK247 assay and had un- with a variant repeat of the circumnsporozoite proexpectedly low activity in the VK211O ELISA tein of'plasmodium uivax. Am. J. Trop. Med. Hvg. (>5-20 pg). In addition, sporozoites produced 43: 446-451. from nine patients (3.8%) were negative in the Ey, P. L., S. J. Prowse & C. R. Jenkin. 1978. Isola- VK2IO0 ELISA and had very low activity in the tion of pure lggj, 1gG, and IgG2,~ immunogloh- VK247 assay V >2.000-16,000 pg). indicating the ulins front nouse serum using protein A-Sepharose. possblepreenc ofa possble Csproeinrepat nit f resnce acs Immunochemnistry potei 15: 429-436. reeat nitgordon. D. NI., T. 'NI. Cosgriff, 1. Schneider, G. significantly F. different than the two published se- Wasserman, W. R. Majarian. NI. R. Hollingdale & quences. The CS genes of these px-asites cur- J.Cua.19.S~~ n mngnct rentlv are being amplified for sequencing, and of' at Plasmodiurn vivax sporozoite vaccine. Am. J the VK1(247 ELISA is being used to screen P. Trop. Med. Hvg. 42: 527-531. iviax sporozoites from different geographic ar- Kain. K. C., R. A. Wirtz, I. Fernandez. E. D. Franke. eas. NI. H. Rodriguez & D. E. Lanar. 1992. Serologic and genetic characterization of Plasmodium vivax fromn %%hole blood impregnated filter paper discs. Acknowledgments Amn. 1. Trop. Med. H-.vg. 46: 473-479. We thank 1'. Charoenvit for the NVS#3 cell line and Rosenberg, R., R. A. Wirtz, D. E. Lanar. J. Satta- R. Ward for his review of the manuscript. Th NSIV20 bongkot. T. Hall. A. P. Waters & C. Prasittisuk. CS protein was furnished by Smith Mline & French 1989. Circumsporozoite protein heterogeneity in Laboratories. Part of this work w,-is completed durini! the humnan malaria parasite Plasniodiumn vivax. Sci- R. Wirtz's U.S. Army. Reserve active-dutit trainingc at eice (Washington. D.C.' 245: 973-976ý the Uniformed Services Universitv of the Healthi Sci- Sattabongkot. J.. N. Nlaneechai & R. Rosenberg. ences. Bethesdla. MID, This research %% as supportedl in 1991. Plo snodiui vt-arx: gametocvte inf -ectivitv part by a UNDPAV'orld Bank/WhlO Special Programmet oif naturaliv infected Thai adults. Parasitology 102: for research and Training in Tropical Diseases.JDR 27-31. grant. The views, of the authors rio not purpo(rt to reflect Wirtz. R. A. & T. R. Burkot. 1991. Detection of mathe position of the Department of' the Army\ or the laniai parasites in mosquitoes. pp. 76-106. In K. F. Department of Defense (para. 4-3. AR 360-5).S Proce- Ha~rris (cr11. Advances in Disease Vector Research. dures for producing sporozoites by feerlini 1 mosqui1toes Spruiger-Verlag. New York. on patients were approverd bv the humian Vise coniniiit- Wirtz, R. A.. Y. Charoenvit. T. R. Burkot. K. MI. Esser, tees of the Ministrv of Public Health. Thailanrd. and the R. L. Beaudoin. W. E. Collins & R. G. Andre. U.S. Army Merdical Research and D~evelopment C;0111i 1991. Eva'aation of monoclonal antibodies against niand. Pla~snioditins Vicar for ELISA development. Med. Vet Entornol. 5: 17-22. Refernces itedwirtz. Refernces itedwebster. R. A.. R. Rosenberg, J. Sattabongkot & H. K. 1990. Prevalence of antibody to heter- Burliot. T. R.. J. L. Williams & 1. Schneider. 1984. ologomis circumisporozoitre protein of' Plasniodiurn Identification of Plasniodiuni falciparurn-intectel rit-ax in Thailandl. Lancet :336: 593-595. nios u i toes 1). as dtou ble anti borl. enizvnie-l inken iimmonosorbent assa\. Arn. J. irop) Med. Hvu. 3-3: Received for publication 27,Januari, 1.992. accepted 783-788. 20A) Aril 1992. LAcesslon For NTIS GRA&I DTIC TAB Unannounced 5 JUaStIfleation Cý By Distributionz/ AvailabilityCo4gm!AV~fE and/or Nest Special 990